Active ingredientAmifampridinCat. No. P-A115-001CAS 54-96-6Family · Pharmaceutical analytical standards
Amifampridin
A potassium channel blocker (3,4-diaminopyridine) that prolongs the release of acetylcholine from nerve endings: approved in Europe in 2009 and in the United States in 2018 for Lambert-Eaton myasthenic syndrome. This family brings together the active ingredient.
Did you know?Discovered in Scotland in the 1970s, it was first used against Lambert-Eaton syndrome by Swedish doctors in the 1980s, long before it had a licensed form.
Go to the active ingredient →Active ingredientAmifampridinCat. No. P-A115-001CAS 54-96-6No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.